glp-1 agonist gastroparesis receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal GLP-1 Gastroparesis: Hidden Dangers Beyond
Description
Glucagon-like peptide-1 receptor agonists and pancreatitis: a meta-analysis of randomized clinical trials
(2021) 33:83344.e5
Am J Prev Cardiol
It works within our body's natural systems rather than overriding them, and so, combined with lifestyle which we should always have lifestyle in there it could be a great natural alternative to at least start with, if you are considering those drugs
doi: 10.1016/j.mce.2014.10.025
